Clindamycin is an orally active and broad-spectrum bacteriostatic lincosamideantibiotic. Clindamycin can inhibitbacterialprotein synthesis, possessing the ability to suppress the expression of virulence factors inStaphylococcus aureusat sub-inhibitory concentrations (sub-MICs). Clindamycin resistance results from enzymatic methylation of theantibioticbinding site in the 50S ribosomal subunit (23S rRNA). Clindamycin decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla). Clindamycin also can be used for researching malaria^[1][2].

424.98

C₁₈H₃₃ClN₂O₅S

18323-44-9

克林霉素；氯洁霉素

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.